Up-Regulation of p53/miR-628-3p Pathway, a Novel Mechanism of Shikonin on Inhibiting Proliferation and Inducing Apoptosis of A549 and PC-9 Non–Small Cell Lung Cancer Cell Lines
Shikonin (SHK) is a pleiotropic agent with remarkable cell growth inhibition activity against various cancer types, especially non–small cell lung cancer (NSCLC), but its molecular mechanism is still unclear. Our previous study found that miR-628-3p could inhibit the growth of A549 cells and induce...
Enregistré dans:
Auteurs principaux: | Jieli Pan, Meiya Li, Fenglin Yu, Feiye Zhu, Linyan Wang, Dandan Ning, Xiaoli Hou, Fusheng Jiang |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/37f8f2e0ccb14e8dafed70c71211a9dc |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Shikonin Induced Program Cell Death through Generation of Reactive Oxygen Species in Renal Cancer Cells
par: Ming-Feng Tsai, et autres
Publié: (2021) -
Deoxyshikonin isolated from Arnebia euchroma inhibits colorectal cancer by down-regulating the PI3K/Akt/mTOR pathway
par: Yuzhen Zhu, et autres
Publié: (2019) -
Successful in vivo hyperthermal therapy toward breast cancer by Chinese medicine shikonin-loaded thermosensitive micelle
par: Su Y, et autres
Publié: (2017) -
The Cross Talk Between p53 and mTOR Pathways in Response to Physiological and Genotoxic Stresses
par: Danrui Cui, et autres
Publié: (2021) -
Role of microRNAs in COVID-19 with implications for therapeutics
par: Nahid Arghiani, et autres
Publié: (2021)